Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Weiden

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Psychiatric Practice|July 2, 2005
Ziprasidone updateP J Weiden
Journal of Psychiatric Practice|July 2, 2005
Ziprasidone: a new atypical antipsychoticP J Weiden
Journal of Psychiatric Practice|July 2, 2005
Trauma and disaster in psychiatrically vulnerable populationsA Pandya, P J Weiden
Schizophrenia Bulletin|January 1, 1995
Cost of relapse in schizophreniaP J Weiden, M Olfson
Journal of Psychiatric Practice|July 2, 2005
Which side effects really matter? Screening for common and distressing side effects of antipsychotic medicationsP J Weiden, A L Miller
The Journal of Clinical Psychiatry|October 3, 1999
Compliance and the rehabilitation allianceR Aquila, P J Weiden, M Emanuel
The Journal of Clinical Psychiatry|June 20, 2001
Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot studyM F Grunebaum, P J Weiden, M Olfson
The Journal of Clinical Psychiatry|December 1, 1989
A comparison of two adjunctive treatment strategies in acute maniaF N Busch, F T Miller, P J Weiden
The Journal of Clinical Psychiatry|December 10, 1998
Long-term considerations after switching antipsychoticsP J Weiden, R Aquila, M Emanuel, et al.
The Journal of Clinical Psychiatry|January 1, 1997
Switching antipsychotic medicationsP J Weiden, R Aquila, L Dalheim, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Psychiatric Practice|July 2, 2005
Ziprasidone updateP J Weiden
Journal of Psychiatric Practice|July 2, 2005
Ziprasidone: a new atypical antipsychoticP J Weiden
Journal of Psychiatric Practice|July 2, 2005
Trauma and disaster in psychiatrically vulnerable populationsA Pandya, P J Weiden
Schizophrenia Bulletin|January 1, 1995
Cost of relapse in schizophreniaP J Weiden, M Olfson
Journal of Psychiatric Practice|July 2, 2005
Which side effects really matter? Screening for common and distressing side effects of antipsychotic medicationsP J Weiden, A L Miller
The Journal of Clinical Psychiatry|October 3, 1999
Compliance and the rehabilitation allianceR Aquila, P J Weiden, M Emanuel
The Journal of Clinical Psychiatry|June 20, 2001
Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot studyM F Grunebaum, P J Weiden, M Olfson
The Journal of Clinical Psychiatry|December 1, 1989
A comparison of two adjunctive treatment strategies in acute maniaF N Busch, F T Miller, P J Weiden
The Journal of Clinical Psychiatry|December 10, 1998
Long-term considerations after switching antipsychoticsP J Weiden, R Aquila, M Emanuel, et al.
The Journal of Clinical Psychiatry|January 1, 1997
Switching antipsychotic medicationsP J Weiden, R Aquila, L Dalheim, et al.
Pageof 3